ClinicalTrials.Veeva

Menu

Comparative Efficacy of Advanced and Traditional Wound Dressings in Post-Operative Orthopedic Care

N

Nidhi Srivastava

Status

Completed

Conditions

Orthopaedics Wound Dressings

Treatments

Device: OPSITE
Device: Traditional Dressing
Device: Aquacel Ag
Device: MEPILEX POST OP BORDER

Study type

Interventional

Funder types

Other

Identifiers

NCT06540040
88/2022

Details and patient eligibility

About

Title: Comparative Efficacy of Advanced and Traditional Wound Dressings in Post-Operative Orthopedic Care: A Randomized Controlled Trial

Objective:

The primary objective of this study is to evaluate and compare the efficacy of advanced wound dressings versus traditional gauze-based dressings in post-operative orthopedic care. The study aims to assess various parameters including patient comfort, pain management, ease of application, exudate management, and the incidence of early surgical site complications.

Full description

Title: Comparative Efficacy of Advanced and Traditional Wound Dressings in Post-Operative Orthopedic Care: A Randomized Controlled Trial

Brief Summary:

This study aims to compare the efficacy of advanced wound dressings with traditional gauze-based dressings in post-operative orthopedic care. The study evaluates patient comfort, pain management, ease of application, exudate management, and the incidence of early surgical site complications.

Study Type: Interventional (Clinical Trial)

Study Design: Randomized Controlled Single-Centre Open-Label Study

Primary Purpose: Treatment

Study Start Date: August 10, 2022

Study Completion Date: December 10, 2022

Primary Completion Date: December 10, 2022

Estimated Enrollment: 320 participants

Intervention Model: Parallel Assignment

Masking: None (Open Label)

Interventions:

Participants undergoing orthopedic surgical procedures were randomized into four groups:

Group A: Aquacel Ag (Hydrofibre wound dressing with ionic silver) Group B: OPSITE (Transparent waterproof cotton pad with high Moisture Vapour Transmission Rate) Group C: MEPILEX POST OP BORDER (4-layer foam dressing with flex technology) Group D: Traditional dressing with gauze pieces, surgical pads, and porous paper adhesive strips

Objectives:

To assess the incidence of early surgical site complications such as blisters, infection, maceration, rashes, redness, swelling, and dehiscence at days 3, 7, and 14.

To determine the pain and discomfort experienced by patients during dressing changes using a visual analog scale.

To evaluate the ability to perform activities of daily living comfortably. To assess nurses' ease of application and removal of the dressings.

Outcome Measures:

Primary Outcome Measures: Incidence of surgical site complications at days 3, 7, and 14.

Secondary Outcome Measures: Pain levels during dressing changes, comfort and mobility in daily activities, ease of application and removal of the dressings, and patient satisfaction.

Data Collection Methods:

Data were collected using a semi-structured questionnaire validated by experts. The questionnaire included a wound assessment checklist, a 10-point Likert scale for patient comfort and mobility, a Visual Analog Scale for pain, and a rating scale for nurses' ease of application and removal.

Statistical Analysis:

Categorical variables were presented as numbers and percentages. Continuous variables were presented as mean ± SD and median values. Data normality was checked using the Kolmogorov-Smirnov test. Quantitative variables were analyzed using ANOVA and Kruskal-Wallis test with post hoc tests as appropriate.

Qualitative variables were analyzed using the Chi-Square test or Fisher's exact test for cells with expected values less than 5.

A p-value of less than 0.05 was considered statistically significant.

Ethics and Registration:

Detailed Description:

This study evaluates the comparative efficacy of different wound dressings used in post-operative orthopedic care. The focus is on advanced dressings such as Aquacel Ag, OPSITE, and MEPILEX POST OP BORDER, compared to traditional gauze-based dressings. The study measures various parameters including patient comfort, pain during dressing changes, ease of application and removal by nurses, and management of wound exudate. Data were collected at three time points: days 3, 7, and 14 post-surgery. The results aim to provide insights into the best practices for post-operative wound management in orthopedic patients.

Enrollment

320 patients

Sex

All

Ages

18 to 90 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age between 18 and 90 years Undergoing orthopedic surgical procedures, elective or trauma, with a surgical wound size of more than 5 cm Provided informed consent

Exclusion criteria

  • Open fractures Revision surgeries Established infections Ongoing pharmacological anticoagulation prophylaxis Predisposing skin conditions Known allergy or hypersensitivity to any of the constituents of the dressings Any associated systemic injury precluding early mobilization Unwillingness to participate

Trial design

Primary purpose

Health Services Research

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

320 participants in 4 patient groups

Aquacel Ag
Experimental group
Description:
Participants in this group will receive Aquacel Ag, a Hydrofibre wound dressing consisting of non-woven sodium carboxymethylcellulose fibres integrated with ionic silver. This dressing is designed to provide a moist wound environment and has antimicrobial properties to help reduce the risk of infection. The dressing will be applied post-operatively and changed as per the standardized protocol.
Treatment:
Device: Aquacel Ag
OPSITE
Experimental group
Description:
Participants in this group will receive OPSITE, a transparent waterproof cotton pad with a high Moisture Vapour Transmission Rate. This dressing is intended to provide a protective barrier while allowing moisture vapor to escape, helping to maintain an optimal wound healing environment. The dressing will be applied post-operatively and changed according to the standardized protocol.
Treatment:
Device: OPSITE
MEPILEX POST OP BORDER
Experimental group
Description:
Participants in this group will receive MEPILEX POST OP BORDER, a 4-layer foam dressing with flex technology. This advanced dressing is designed to provide superior absorption and conformability, helping to manage exudate and protect the wound site. The dressing will be applied post-operatively and changed as per the standardized protocol.
Treatment:
Device: MEPILEX POST OP BORDER
Traditional Dressing
Active Comparator group
Description:
Participants in this group will receive traditional wound dressings consisting of gauze pieces, surgical pads, and porous paper adhesive strips. This type of dressing is commonly used in post-operative care to absorb exudate and protect the wound site. The dressing will be applied post-operatively and changed according to the standardized protocol.
Treatment:
Device: Traditional Dressing

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems